Suppr超能文献

钙蛋白酶抑制后神经突生长的增强由蛋白激酶C介导。

Enhancement of neurite outgrowth following calpain inhibition is mediated by protein kinase C.

作者信息

Shea T B, Cressman C M, Spencer M J, Beermann M L, Nixon R A

机构信息

Department of Biological Sciences, University of Massachusetts at Lowell 01854, USA.

出版信息

J Neurochem. 1995 Aug;65(2):517-27. doi: 10.1046/j.1471-4159.1995.65020517.x.

Abstract

We examined the interdependence of calpain and protein kinase C (PKC) activities on neurite outgrowth in SH-SY-5Y human neuroblastoma cells. SH-SY-5Y cells elaborated neurites when deprived of serum or after a specific thrombin inhibitor, hirudin, was added to serum-containing medium. The extent of neurite outgrowth under these conditions was enhanced by treatment of cells with the cell-permeant cysteine protease inhibitors N-acetyl-leucyl-leucyl-norleucinal ("C1") and calpeptin or by the phospholipid-mediated intracellular delivery of either a recombinant peptide corresponding to a conserved inhibitory sequence of human calpastatin or a neutralizing anti-calpain antisera. Calpain inhibition in intact cells was confirmed by immunoblot analysis showing inhibition of calpain autolysis and reduced proteolysis of the known calpain substrates fodrin and microtubule-associated protein 1. The above inhibitory peptides and antiserum did not induce neurites in medium containing serum but lacking hirudin, suggesting that increased surface protein adhesiveness is a prerequisite for enhancement of neurite outgrowth by calpain inhibition. Treatment of cells with the PKC inhibitor H7, staurosporine, or sphingosine induced neurite outgrowth independently of serum concentration. Because calpain is thought to regulate PKC activity, we examined this potential interrelationship during neurite outgrowth. Simultaneous treatment with calpain and PKC inhibitors did not produce additive or synergistic effects on neurite outgrowth. PKC activation by 2-O-tetradecanoylphorbol 13-acetate (TPA) prevented and reversed both neurite initiation by serum deprivation and its enhancement by calpain inhibitors. Treatment of cells with the calpain inhibitor C1 retarded PKC down-regulation following TPA treatment. Cell-free analyses demonstrated the relative specificity of various protease and kinase inhibitors for calpain and PKC and confirmed the ability of millimolar calcium-requiring calpain to cleave the SH-SY-5Y PKC regulatory subunit from the catalytic subunit, yielding a free catalytic subunit (protein kinase M). These findings suggest that the influence of PKC on neurite outgrowth is downstream from that of surface adhesiveness and calpain activity.

摘要

我们研究了钙蛋白酶和蛋白激酶C(PKC)活性对SH-SY-5Y人神经母细胞瘤细胞神经突生长的相互依赖性。当剥夺血清时,或在向含血清培养基中添加特异性凝血酶抑制剂水蛭素后,SH-SY-5Y细胞会长出神经突。在这些条件下,用细胞渗透性半胱氨酸蛋白酶抑制剂N-乙酰-亮氨酰-亮氨酰-正亮氨酸(“C1”)和钙蛋白酶抑制素处理细胞,或通过磷脂介导的细胞内递送对应于人钙蛋白酶抑制蛋白保守抑制序列的重组肽或中和性抗钙蛋白酶抗血清,可增强神经突生长的程度。通过免疫印迹分析证实完整细胞中的钙蛋白酶受到抑制,该分析显示钙蛋白酶自溶受到抑制,已知的钙蛋白酶底物血影蛋白和微管相关蛋白1的蛋白水解减少。上述抑制性肽和抗血清在含血清但不含水蛭素的培养基中不会诱导神经突生长,这表明增加表面蛋白粘附性是通过抑制钙蛋白酶增强神经突生长的前提条件。用PKC抑制剂H7、星形孢菌素或鞘氨醇处理细胞可诱导神经突生长,且与血清浓度无关。由于钙蛋白酶被认为可调节PKC活性,我们在神经突生长过程中研究了这种潜在的相互关系。同时用钙蛋白酶和PKC抑制剂处理对神经突生长没有产生相加或协同作用。2-十四烷酰佛波醇-13-乙酸酯(TPA)激活PKC可阻止并逆转血清剥夺诱导的神经突起始及其被钙蛋白酶抑制剂增强的作用。用钙蛋白酶抑制剂C1处理细胞可延缓TPA处理后PKC的下调。无细胞分析证明了各种蛋白酶和激酶抑制剂对钙蛋白酶和PKC的相对特异性,并证实了需要毫摩尔钙的钙蛋白酶能够从催化亚基上切割SH-SY-5Y PKC调节亚基,产生游离的催化亚基(蛋白激酶M)。这些发现表明,PKC对神经突生长的影响位于表面粘附性和钙蛋白酶活性的下游。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验